Cargando…
Minimal Ureagenesis is Necessary for Survival in the Murine Model of Hyperargininemia Treated by AAV-based Gene Therapy
Hyperammonemia is less severe in arginase 1 deficiency compared with other urea cycle defects. Affected patients manifest hyperargininemia and infrequent episodes of hyperammonemia. Patients typically suffer from neurological impairment with cortical and pyramidal tract deterioration, spasticity, lo...
Autores principales: | Hu, Chuhong, Tai, Denise S., Park, Hana, Cantero-Nieto, Gloria, Chan, Emily, Yudkoff, Marc, Cederbaum, Stephen D., Lipshutz, Gerald S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320015/ https://www.ncbi.nlm.nih.gov/pubmed/25474440 http://dx.doi.org/10.1038/gt.2014.106 |
Ejemplares similares
-
AAV-based Neonatal Gene Therapy for Hemophilia A: Long-Term Correction and Avoidance of Immune Responses in Mice
por: Hu, Chuhong, et al.
Publicado: (2012) -
Restoring Ureagenesis in Hepatocytes by CRISPR/Cas9-mediated Genomic Addition to Arginase-deficient Induced Pluripotent Stem Cells
por: Lee, Patrick C, et al.
Publicado: (2016) -
Arginine to ornithine ratio as a diagnostic marker in patients with positive newborn screening for hyperargininemia
por: Huang, Yue, et al.
Publicado: (2021) -
AAV-based Gene Therapy Prevents Neuropathology and Results in Normal Cognitive Development in the Hyperargininemic Mouse
por: Lee, Eun K., et al.
Publicado: (2013) -
Hyperargininemia Presenting as Intermittent Ataxia and Cerebellar Atrophy
por: Cornelius, Leema P., et al.
Publicado: (2020)